Results 91 to 100 of about 9,470 (201)

Aromatic C-nitrosation of a bioactive molecule. Nitrosation of minoxidil

, 2011
Minoxidil (2,4-diamino-6-(piperidin-1′-yl)pyrimidine N(3)-oxide; CASRN 38304-91-5) is a bioactive molecule with several nitrosatable groups widely used as an antihypertensive and antialopecia agent. Here the nitrosation of minoxidil was investigated. The
Calle, Emilio, Casado, Julio, Arenas-Valgañón, Jorge, González-Jiménez, Mario, Jorge Arenas-Valgañón, Julio Casado, Mario González-Jiménez, Emilio Calle   +7 more
core   +1 more source

Applications and efficacy of minoxidil in dermatology

Minoxidil, originally developed as an antihypertensive medication, has evolved into a versatile therapeutic agent within dermatology, notably for its effectiveness in promoting hair growth.
Abeer Ali El‐Sherbiny, Salman Bin Dayel, Ramadan S. Hussein, Othman Abahussein   +3 more
core   +1 more source

Summation and Recommendations for the Safe and Effective Use of Topical and Oral Minoxidil [PDF]

BackgroundTopical minoxidil, approved for the treatment of androgenetic alopecia, also has efficacy in many other hair loss disorders, its use is limited due to the need for at least daily application. Oral minoxidil, in doses below those likely to lower
Bergfeld, Wilma, Hordinsky, Maria, Shapiro, Jerry, Mesinkovska, Natasha A, Sadick, Neil, Olsen, Elise A, Sinclair, Rodney   +6 more
core   +1 more source

Investigation on the Effect of 7% Chamomile Extract on Cutaneous Side Effects of Minoxidil in Treatment of Male Androgenetic Alopecia

Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk, 2019
Background and Aim Male Androgenic Alopecia (MAA) is one of the most common causes of hair loss in men. Minoxidil solution is one of the most commonly used medications for MAA treatment; however, it has several cutaneous side effects including itching ...
Mina Mirnezami, Bahman Sadeghi, Sajid Ghadbighi, Farid Sahabi, Mojtaba Ahmadloo   +4 more
doaj  

Dermatitis alérgica de contacto por el principio activo de un preparado de minoxidil

, 2003
Minoxidil tópico suele utilizarse para tratar la alopecia androgénica. Se calcula una incidencia de dermatitis alérgica de contacto (DAC) por preparados de minoxidil del 1-3,7%.
Rodríguez Trabado, A., Jiménez Timón, S., Fletes Peral, C., Poncel Carreño, S. L., Rodríguez Martín, E.   +4 more
core  

MINOXIDIL ORAL E SUA EFICÁCIA NO TRATAMENTO DA ALOPECIA [PDF]

Minoxidil began to be implemented in the 1970s to treat severe refractory hypertension due to its vasodilatory properties. Unintentionally, early trials of oral minoxidil as an antihypertensive medication documented side effects such as hypertrichosis ...
Azara de Oliveira, Eric, Caixeta Ferri, Giulian, Rezende Groschel, Bruna, Ferracioli Alvarenga, Gabriel Henrique, Teixeira de Assis Carvalho, Guilherme   +4 more
core   +1 more source

Supplementary Material for: From hair loss to vision loss: Minoxidil-associated CRVO in a young female

Central retinal vein occlusion (CRVO) is a common retinal vascular disorder that is most often seen in older adults and individuals with vascular risk factors.
Sivachandran N. (17986810), Ji P.X. (17986804), Pickel L. (17986801), Abdelazim A. (17986807)   +3 more
core   +1 more source

Facial hair enhancement with minoxidil—an off-label use

SAGE Open Medical Case Reports
Minoxidil was first introduced in the 1970s as an anti-hypertensive medication. Hypertrichosis and scalp hair regrowth were noted by users, and the topical formulation of minoxidil was later approved by the Food and Drug Administration for androgenic ...
Arveen Shokravi, Hanieh Zargham
doaj   +1 more source

Xerostomia as a Rare Adverse Effect of Low‐Dose Oral Minoxidil: A Case Report With Recurrence After Rechallenge

Clinical Case Reports
Low‐dose oral minoxidil (LDOM) is an emerging option for the treatment of female pattern hair loss (FPHL), generally well tolerated at doses under 1 mg/day.
Nicolò Rivetti
doaj   +1 more source

Minoxidil: New Areas of Opportunity!

Introduction: Minoxidil is a compound chemically synthesized in the laboratory, it underwent clinical trials in hypertensive patients in 1961. Objective: To carry out art history based on an exhaustive search of the national and international medical ...
Oscar Gregorio Ramírez Gamboa, Morelos Adolfo García Sánchez, Luis Alberto González Valdez, Zarah Georgina Pérez Diosdado, Marco Antonio Hernández Hernández, Mariana Carolina Zúñiga García, Karla Lizeth Martínez González, Rafael Martínez Sanciprián, Melba Michelle Romero Ovando, Luis Octavio Victoria García, Miranda Llama Luna   +10 more
core   +1 more source